blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0774962

EP0774962 - USE OF DHA IN THE TREATMENT OF DYSLEXIA [Right-click to bookmark this link]
Former [1997/22]USE OF DHA AS A PHARMACEUTICAL COMPOSITION
[2003/45]
StatusNo opposition filed within time limit
Status updated on  25.02.2005
Database last updated on 19.07.2024
Most recent event   Tooltip17.04.2015Change - lapse in a contracting statepublished on 20.05.2015  [2015/21]
Applicant(s)For all designated states
N.V. Nutricia
Stationsstraat 186
2712 HM Zoetermeer / NL
[N/P]
Former [2002/37]For all designated states
N.V. Nutricia
Stationsstraat 186
NL-2712 HM Zoetermeer / NL
Former [2002/35]For all designated states
Nutricia N.V.
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Former [1997/45]For all designated states
SCOTIA HOLDINGS PLC
Weyvern House, Weyvern Park, Portsmouth Road, Peasmarsh
Guildford GU3 1NA / GB
Former [1997/22]For all designated states
SCOTIA HOLDINGS PLC
Efamol House Woodbridge Meadows
Guildford Surrey GU1 1BA / GB
Inventor(s)01 / STORDY, Barbara Jacqueline
Weyvern House, Weyvern Park, Portsmouth Road
Peasmarsh, Guildford, Surrey GU3 1NA / GB
[1997/22]
Representative(s)van Westenbrugge, Andries, et al
Nederlandsch Octrooibureau
P.O. Box 29720
NL-2502 LS The Hague / NL
[N/P]
Former [2008/22]van Westenbrugge, Andries, et al
Postbus 29720
2502 LS Den Haag / NL
Former [2003/16]van Westenbrugge, Andries, et al
Nederlandsch Octrooibureau P.O. Box 29720
2502 LS The Hague / NL
Former [2002/35]Hutter, Jacobus Johannes, et al
Nederlandsch Octrooibureau P.O. Box 29720
2502 LS Den Haag / NL
Former [1997/40]Farwell, William Robert, et al
PHILLIPS & LEIGH 7 Staple Inn High Holborn
London WC1V 7QF / GB
Former [1997/22]Sturt, Clifford Mark, et al
J. MILLER & CO. 34 Bedford Row, Holborn
London WC1R 4JH / GB
Application number, filing date96919911.624.05.1996
[1997/22]
WO1996GB01265
Priority number, dateGB1995001063625.05.1995         Original published format: GB 9510636
[1997/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9637200
Date:28.11.1996
Language:EN
[1996/52]
Type: A1 Application with search report 
No.:EP0774962
Date:28.05.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 28.11.1996 takes the place of the publication of the European patent application.
[1997/22]
Type: B1 Patent specification 
No.:EP0774962
Date:21.04.2004
Language:EN
[2004/17]
Search report(s)International search report - published on:EP28.11.1996
ClassificationIPC:A61K31/202, A61K31/557, A61P25/00
[2003/45]
CPC:
A61K31/202 (EP,US); A61K31/20 (EP,KR,US); A61P25/00 (EP);
A61P25/28 (EP); A61P27/02 (EP)
C-Set:
A61K31/20, A61K2300/00 (US,EP);
A61K31/20, A61K31/20 (EP,US)
Former IPC [1997/22]A61K31/20, // (A61K31/20, 31:20)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/22]
TitleGerman:VERWENDUNG VON DHA IN DER BEHANDLUNG VON DYSLEXIE[2003/45]
English:USE OF DHA IN THE TREATMENT OF DYSLEXIA[2003/45]
French:UTILISATION DE L'ACIDE DOCOSAHEXANOIQUE (DHA)DANS LE TRAITEMENT DE LA DYSLEXIE[2003/45]
Former [1997/22]VERWENDUNG VON DHA ALS PHARMAZEUTISCHES PRÄPARAT
Former [1997/22]USE OF DHA AS A PHARMACEUTICAL COMPOSITION
Former [1997/22]UTILISATION DE L'ACIDE DOCOSAHEXANOIQUE (DHA) EN TANT QUE COMPOSITION PHARMACEUTIQUE
Entry into regional phase29.01.1997National basic fee paid 
29.01.1997Designation fee(s) paid 
29.01.1997Examination fee paid 
Examination procedure01.02.1997Examination requested  [1997/22]
25.09.2000Despatch of a communication from the examining division (Time limit: M04)
26.01.2001Reply to a communication from the examining division
10.04.2001Despatch of a communication from the examining division (Time limit: M06)
23.10.2001Application deemed to be withdrawn, date of legal effect  [2002/18]
27.11.2001Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2002/18]
05.07.2002Reply to a communication from the examining division
18.11.2002Despatch of a communication from the examining division (Time limit: M04)
17.02.2003Reply to a communication from the examining division
02.05.2003Despatch of a communication from the examining division (Time limit: M04)
24.07.2003Reply to a communication from the examining division
22.10.2003Communication of intention to grant the patent
18.02.2004Fee for grant paid
18.02.2004Fee for publishing/printing paid
Opposition(s)24.01.2005No opposition filed within time limit [2005/15]
Request for further processing for:05.07.2002Request for further processing filed
05.07.2002Full payment received (date of receipt of payment)
Request granted
08.11.2002Decision despatched
Fees paidRenewal fee
12.05.1998Renewal fee patent year 03
07.05.1999Renewal fee patent year 04
11.05.2000Renewal fee patent year 05
17.05.2001Renewal fee patent year 06
30.05.2002Renewal fee patent year 07
14.05.2003Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2007/16]LU21.06.2004
Cited inInternational search[Y]EP0599576  (SCOTIA HOLDINGS PLC [GB]) [Y] 1-9 * column W *;
 [PY]EP0711503  (SCOTIA HOLDINGS PLC [GB]) [PY] 1-9* column W *;
 [X]  - HOLMAN ET AL, "ABNORMAL PLASMA LIPIDS OF PATIENTS WITH RETINITS PIGMENTOSA", LIPIDS, USA, vol. 29, no. 1, pages 61 - 65, XP000600054 [X] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1007/BF02537092
 [PY]  - HORROBIN ET AL, "POSSIBLE RELEVANCE OF PHOSPHOLIPID ABNORMALITIES AND GENETIC INTERACTIONS IN PSYCHIATRIC DISORDERS: THE RELATIONSHIP BETWEEN DYSLEXIA AND SCHIZOPHRENIA", MEDICAL HYPOTHESIS, USA, vol. 45, no. 6, pages 605 - 613, XP000600048 [PY] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1016/0306-9877(95)90246-5
 [PY]  - M.MAKRIDES ET AL, "ARE LONG-CHIN POLYUNSATURATED FATTY ACIDS ESSENTIAL NUTRIENTS IN INFANCY?", LANCET, vol. 345, no. 8963, pages 1463 - 1468, XP000579670 [PY] 1-3 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0140-6736(95)91035-2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.